Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: Early Clinical Experience

被引：0

作者：

Weber, Donna ^{[1
]}

Badros, Ashraf Z. ^{[2
]}

Jagannath, Sundar ^{[3
]}

Siegel, David ^{[4
]}

Richon, Victoria ^{[5
]}

Rizvi, Syed ^{[5
]}

Garcia-Vargas, Jose ^{[5
]}

Reiser, David ^{[5
]}

Anderson, Kenneth C. ^{[6
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphona & Myeloma, Houston, TX 77030 USA

[2] Univ Maryland, Baltimore, MD 21201 USA

[3] St Vincents Comp Canc Ctr, New York, NY USA

[4] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[5] Merck & Co Inc, Upper Gwynedd, PA USA

[6] Dana Farber Canc Inst, Brookline, MA USA

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：322 / 322

页数：1

共 50 条

[1] Early Trials Evaluating Vorinostat plus Bortezomib in Relapsed/Refractory Multiple Myeloma
不详
[J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03): : 199 - 200
[2] Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: A Case Series Illustrating Utility in Clinical Practice
Mazumder, Amitabha
Vesole, David H.
Jagannath, Sundar
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 149 - 151
[3] Vorinostat, Bortezomib, Cyclophosphomide, Thalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Gleason, Charise
Kaufman, Jonathan L.
Nooka, Ajay K.
Valla, Kelly
Heffner, Leonard T.
Bisht, Aditya Singh
Manubolu, Sanjay
Watson, Melanie
Boise, Lawrence H.
Lonial, Sagar
[J]. BLOOD, 2014, 124 (21)
[4] Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Badros, Ashraf
Burger, Angelika M.
Philip, Sunita
Niesvizky, Ruben
Kolla, Sarah S.
Goloubeva, Olga
Harris, Carolynn
Zwiebel, James
Wright, John J.
Espinoza-Delgado, Igor
Baer, Maria R.
Holleran, Julianne L.
Egorin, Merrill J.
Grant, Steven
[J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5250 - 5257
[5] Phase I trial of vorinostat plus bortezomib (bort) in relapsed/refractory multiple myeloma (mm) patients (pts)
Badros, A. Z.
Philip, S.
Niesvizk, R.
Goloubeva, O.
Harris, C.
Zweibel, J.
Wright, J. J.
Burger, A.
Baer, M. R.
Egorin, M. J.
Grant, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] PHASE I TRIAL OF VORINOSTAT PLUS BORTEZOMIB (BORT) IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (MM) PATIENTS (PTS)
Badros, Z.
Philip, S.
Niesvizky, R.
Goloubeva, O.
Harris, C.
Zweibel, J.
Wright, J.
Burger, A.
Baer, M.
Egorin, M.
Grant, S.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 258 - 258
[7] Vorinostat Combined with Bortezomib In Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Update on the Vantage Study Program
Siegel, David S.
Jagannath, Sundar
Hajek, Roman
Dimopoulos, Meletios A.
Yoon, Sung-Soo
Lonial, Sagar
Laubach, Jacob P.
Graef, Thorsten
Pietrangelo, Dina
Lupinacci, Lisa
Reiser, David
Anderson, Kenneth C.
[J]. BLOOD, 2010, 116 (21) : 813 - 814
[8] Bortezomib in Relapsed/Refractory Multiple Myeloma
Shen, Z.
Wang, L.
Yan, H.
[J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62
[9] EFFICACY AND SAFETY OF BORTEZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Sanchez, R. Garcia
Saldana, R.
Caparros, I.
Gallardo, A.
Garcia-Delgado, R.
Rosell, A.
Campos, A.
de Llano, M. P. Queipo
Perez, I.
Moreno, M. J.
Del Castillo, S.
De la Torre, S.
Ramirez, G.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 500 - 500
[10] COMBINED VORINOSTAT AND BORTEZOMIB IN BORTEZOMIB-REFRACTORY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INTERIM ANALYSIS OF A PHASE IIB STUDY
Siegel, D.
Jagannath, S.
Lonial, S.
Dimopoulos, M.
Yoon, S. S.
Graef, T.
Pitrangelo, D.
Lupinacci, L.
Reiser, D.
Anderson, K.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 156 - 157

← 1 2 3 4 5 →